{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:10:19Z","timestamp":1784308219668,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.schres.2009.03.004","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T09:57:26Z","timestamp":1237975046000},"page":"72-79","source":"Crossref","is-referenced-by-count":18,"title":["Subjective wellbeing under quetiapine treatment: Effect of diagnosis, mood state, and anxiety"],"prefix":"10.1016","volume":"110","author":[{"given":"Martin","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Karow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benno G.","family":"Schimmelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2009.03.004_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jad.2007.05.020","article-title":"Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes","volume":"105","author":"Albert","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2009.03.004_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0924-9338(01)00559-4","article-title":"Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences","volume":"16","author":"Benabarre","year":"2001","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.schres.2009.03.004_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpsychires.2004.09.003","article-title":"Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life","volume":"39","author":"Braga","year":"2005","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2009.03.004_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1440-1819.2004.01237.x","article-title":"Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis","volume":"58","author":"Chand","year":"2004","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2009.03.004_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00213-002-1054-x","article-title":"Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale","volume":"162","author":"De Haan","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.schres.2009.03.004_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2008-1076729","article-title":"Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia","volume":"41","author":"de Haan","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2009.03.004_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1176\/ajp.156.3.426","article-title":"Phenomenology of mania: evidence for distinct depressed, dysphoric, and euphoric presentations","volume":"156","author":"Dilsaver","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"suppl 4","key":"10.1016\/j.schres.2009.03.004_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2007-1014552","article-title":"Chapter V (F) of ICD-10: mental, behavioural and developmental disorders \u2013 introduction and overview","volume":"23","author":"Dittmann","year":"1990","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2009.03.004_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1185\/030079906X162809","article-title":"Quetiapine augmentation of treatment-resistant depression: a comparison with lithium","volume":"23","author":"Dor\u00e9e","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.schres.2009.03.004_bib10","unstructured":"Gaebel, W., Falkai, P., 2000. Praxisleitlinien in Psychiatrie und Psychotherapie: Behandlungsleitlinie Affektive Erkrankungen. Steinkopff Verlag Darmstadt."},{"key":"10.1016\/j.schres.2009.03.004_bib11","unstructured":"Gaebel, W., Falkai, P., 2006. Praxisleitlinien in Psychiatrie und Psychotherapie: Behandlungsleitlinie Schizophrenie. Steinkopff Verlag Darmstadt."},{"key":"10.1016\/j.schres.2009.03.004_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1590\/S1516-44462006000200004","article-title":"Bipolar depression: the importance of being on remission","volume":"28","author":"Gazalle","year":"2006","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.schres.2009.03.004_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.psychres.2006.07.007","article-title":"Manic symptoms and quality of life in bipolar disorder","volume":"153","author":"Gazalle","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2009.03.004_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/JGP.0b013e318065b06b","article-title":"Comparison of older patients with bipolar disorder and schizophrenia\/schizoaffective disorder","volume":"15","author":"Gupta","year":"2007","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2009.03.004_bib15","series-title":"US Dept Health, Education, and Welfare publication (ADM) 76-338","first-page":"218","article-title":"ECDEU Assessment Manual for Psychopharmacology, revised","author":"Guy","year":"1976"},{"issue":"suppl. 416","key":"10.1016\/j.schres.2009.03.004_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","volume":"107","author":"Haro","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2009.03.004_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4088\/JCP.v67n0304","article-title":"Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study","volume":"67","author":"Hirschfeld","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.03.004_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(99)00151-6","article-title":"Quality of life in schizophrenia: contributions of anxiety and depression","volume":"51","author":"Huppert","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2009.03.004_bib20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000088921","article-title":"PANSS syndromes and quality of life in schizophrenia","volume":"38","author":"Karow","year":"2005","journal-title":"Psychopathology"},{"key":"10.1016\/j.schres.2009.03.004_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4088\/JCP.v68n0110","article-title":"Association of subjective wellbeing, symptoms and side effects with compliance after 12\u00a0month treatment in schizophrenia","volume":"68","author":"Karow","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.03.004_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/070674370705200309","article-title":"Anxiety comorbidity and quality of life in bipolar disorder patients","volume":"52","author":"Kauer-Sant'Anna","year":"2007","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.schres.2009.03.004_bib23","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2165\/00003495-200767070-00008","article-title":"Quetiapine: a review of its use in the treatment of bipolar depression","volume":"67","author":"Keating","year":"2007","journal-title":"Drugs"},{"issue":"suppl 1","key":"10.1016\/j.schres.2009.03.004_bib24","first-page":"5","article-title":"Prevalence and impact of comorbid anxiety and bipolar disorder","volume":"67","author":"Keller","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.03.004_bib25","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.4088\/JCP.v67n1104","article-title":"Prediction of remission as a combination of symptomatic and functional remission and adequate subjective wellbeing in 2960 patients with schizophrenia","volume":"67","author":"Lambert","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.03.004_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/13651500600649929","article-title":"Clinical effectiveness of quetiapine: findings of a post-marketing surveillance study in patients with schizophrenia","volume":"10","author":"Lambert","year":"2006","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.schres.2009.03.004_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0447.2006.00862.x","article-title":"Remission of severely impaired subjective well-being in 727 patients with schizophrenia treated with amisulpride","volume":"115","author":"Lambert","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2009.03.004_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0447.2008.01213.x","article-title":"Predicting remission and recovery in 392 never-treated patients with schizophrenia","volume":"118","author":"Lambert","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2009.03.004_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.schres.2008.08.035","article-title":"Long-term cluster of subjective wellbeing in schizophrenia: prediction of cluster affiliation and their predictive value for recovery in 2842 patients followed over 3\u00a0years","volume":"107","author":"Lambert","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2009.03.004_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1081\/BIP-100104194","article-title":"Accounting for dropout bias using mixed-effects models","volume":"11","author":"Mallinckrodt","year":"2001","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.schres.2009.03.004_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1191\/1740774504cn049oa","article-title":"The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA","volume":"1","author":"Mallinckrodt","year":"2004","journal-title":"Clin. Trials"},{"key":"10.1016\/j.schres.2009.03.004_bib41","doi-asserted-by":"crossref","unstructured":"Naber, D., Moritz, S., Lambert, M., Pajonk, F.G., Holzbach, R., Mass, R., Andresen, B., 2001. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr. Res. 50, 79\u201388.","DOI":"10.1016\/S0920-9964(00)00166-3"},{"key":"10.1016\/j.schres.2009.03.004_bib32","doi-asserted-by":"crossref","unstructured":"Perkins, D.O., Johnson, J.L.,Hamer, R.M., Zipursky, R.B.,Keefe, R.S., Centorrhino, F., Green, A.I., Glick, I.B., Kahn, R.S., Sharma, T., Tohen,M., McEvoy, J.P.,Weiden, P.J., Lieberman, J.A., HGDH Research Group, 2006. Predictors of antipsycho- tic medication adherence in patients recovering from a first psychotic episode. Schizophr. Res. 83, 53\u201363.","DOI":"10.1016\/j.schres.2005.10.016"},{"issue":"suppl. 416","key":"10.1016\/j.schres.2009.03.004_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1034\/j.1600-0447.107.s416.6.x","article-title":"A Rasch model analysis to test the cross-cultural validity of the EuroQoL-5D in the Schizophrenia Outpatient Health Outcomes Study","volume":"107","author":"Prieto","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2009.03.004_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/cap.2005.15.249","article-title":"Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics","volume":"15","author":"Schimmelmann","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.schres.2009.03.004_bib35","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v68n0811","article-title":"Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression","volume":"68","author":"Simon","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.03.004_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1600-0447.2007.01072.x","article-title":"Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects","volume":"116","author":"Torrent","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2009.03.004_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.schres.2006.12.017","article-title":"Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia","volume":"91","author":"Wehmeier","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2009.03.004_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.pnpbp.2007.01.004","article-title":"Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia","volume":"30","author":"Wehmeier","year":"2007","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2009.03.004_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.comppsych.2005.08.001","article-title":"Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants","volume":"47","author":"Zhang","year":"2006","journal-title":"Compr. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996409000899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996409000899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T16:05:17Z","timestamp":1684944317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996409000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":39,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0920996409000899"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2009.03.004","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}